Gammadelta T cell is to be administrated intravenously four times on a biweekly-basis.

2 trials

Sponsors

Japanese Red Cross Medical Center

Conditions

Multiple myeloma

Unknown Phase

Clinical dose-escalation study of auto-gammadelta T cell therapy for multiple myeloma to investigate its safety and efficacy

Active, not recruitingJPRN-C000000343

Japanese Red Cross Medical CenterMultiple myeloma

Start: 2005-11-01Target: 4Updated: 2026-06-29

Clinical dose-escalation study of auto-gammadelta T cell therapy for multiple myeloma to investigate its safety and efficacy

Active, not recruitingJPRN-UMIN000000554

Japanese Red Cross Medical CenterMultiple myeloma

Start: 2006-09-01Target: 6Updated: 2026-06-29